| abstract |
REFERS TO CYCLOHEXANE-1,4-DIAMINE DERIVATIVES SUBSTITUTED FOR FORMULA I WHERE R1 AND R2 ARE H, C1-C8 ALKYL, C3-C8 CYCLOALKYL, AMONG OTHERS; R1 AND R2 TOGETHER FORM A CH2CH2OCH2CH2, CH2CH2NR6CH2CH2 O (CH2) 3-6 CYCLE R6 being H, C1-C8 ALKYL, C3-C8 CYCLOALKYL, AMONG OTHERS; R3 IS H, C1-C8 ALKYL, AMONG OTHERS; R4 IS H, C1-C8 ALKYL, AMONG OTHERS; R5 IS C3-C8 CYCLOALKYL, ARYL, HETEROARYL, AMONG OTHERS. N'-BENZYL-N, N-DIMETHYL-1-PHENYL-CYCLOHEXANE-1,4-DIAMINE LESS POLAR DIASTEREOMER HYDROCHLORIDE, N'-BENZYL-N, N-DIMETHYL-1-PHENYL-CYCLOHEXANE-1,4 HYDROCHLORIDE -DIAMINE DIASTEREOMER MORE POLAR. IT ALSO REFERS TO A PROCEDURE FOR ITS PREPARATION. THE MENTIONED COMPOUNDS HAVE SELECTIVITY FOR THE ORL1 RECEPTOR (SIMILAR TO THE OPIOID RECEIVER) |